Trials / Unknown
UnknownNCT02618057
Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia
Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia With Lobar Consolidation or Pleural Effusion in Children
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children.
Detailed description
Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe pneumonia can develop despite appropriate antibiotic therapy. The investigators aim to study the effects of prednisolone on severe M. pneumoniae pneumonia with lobar consolidation or pleural effusion in children. Participants will be randomly assigned (1:1 ratio) to receive either prednisone 1 mg/kg/d daily for 5 days or none. The primary endpoint was fever duration and analysed by intention to treat.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisolone | PO prednisolone, 1 mg/kg/day, for 5 days |
| DRUG | Levofloxacin | Levofloxacin, 10mg/kg/day, IV, for 5days |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2015-12-01
- Last updated
- 2018-04-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02618057. Inclusion in this directory is not an endorsement.